Chia‐Ron Yang
Impact in
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
Papers in
-
- Histone Deacetylase Inhibitors Research 15
- Protein Degradation and Inhibitors 5
- Oncology 12
- Peptidase Inhibition and Analysis 6
- Cancer-related Molecular Pathways 4
- Co-authors
- Jing‐Ping Liou (18 shared papers)Wan‐Wan Lin (4 shared papers)Che‐Ming Teng (10 shared papers)Shie-Liang Hsieh (3 shared papers)Jyh‐Horng Wang (5 shared papers)Feng‐Ming Ho (2 shared papers)Hsueh‐Yun Lee (9 shared papers)Yiwen Wu (5 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (5 papers)European Journal of Medicinal Chemistry (3 papers)Oncotarget (3 papers)Journal of Medicinal Chemistry (2 papers)Shock (2 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Chia‐Ron Yang
51 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 109
- Pharmacology 212
- Molecular Biology 908
- Cancer Research 176
- Oncology 269
- Immunology 215
Countries citing papers authored by Chia‐Ron Yang
This map shows the geographic impact of Chia‐Ron Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Ron Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Ron Yang more than expected).
Fields of papers citing papers by Chia‐Ron Yang
This network shows the impact of papers produced by Chia‐Ron Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Ron Yang. The network helps show where Chia‐Ron Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chia‐Ron Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 220 | |
| 2 | 2004 | 97 | |
| 3 | 2018 | 84 | |
| 4 | 2005 | 83 | |
| 5 | 2013 | 83 | |
| 6 | 2004 | 75 | |
| 7 | 2018 | 72 | |
| 8 | 2011 | 61 | |
| 9 | 2018 | 59 | |
| 10 | 2014 | 50 | |
| 11 | 2014 | 45 | |
| 12 | 2021 | 41 | |
| 13 | 2016 | 40 | |
| 14 | 2008 | 37 | |
| 15 | 2016 | 36 | |
| 16 | 2019 | 35 | |
| 17 | 2008 | 32 | |
| 18 | Unsuspected Prostate Carcinoma and Prostatic Intraepithelial Neoplasm in Taiwanese Patients Undergoing Cystoprostatectomy. | 1999 | 31 |
| 19 | 2012 | 28 | |
| 20 | 2019 | 28 |
About Chia‐Ron Yang
Chia‐Ron Yang is a scholar working on Molecular Biology, Oncology, Immunology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 52 papers that have together received 1.6k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (15 papers), Peptidase Inhibition and Analysis (6 papers), Protein Degradation and Inhibitors (5 papers), Computational Drug Discovery Methods (5 papers), Immune Response and Inflammation (4 papers), Alzheimer's disease research and treatments (4 papers), Cancer-related Molecular Pathways (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Pharmacology (212 citations), Molecular Biology (908 citations), Cancer Research (176 citations), Oncology (269 citations) and Immunology (215 citations). Chia‐Ron Yang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Jing‐Ping Liou, Wan‐Wan Lin, Che‐Ming Teng, Shie-Liang Hsieh, Jyh‐Horng Wang, Feng‐Ming Ho, Hsueh‐Yun Lee, Yiwen Wu, Lian‐Yu Lin and Shing‐Hwa Liu. Their work appears in journals such as Biomedicine & Pharmacotherapy, European Journal of Medicinal Chemistry, Oncotarget, Journal of Medicinal Chemistry and Shock.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.